Follow NCPIE on Facebook

View our YouTube channel

Please consult a licensed health care professional with questions or concerns about your medication and/or condition.

Last Updated
March 8, 2017
NEWSROOM > Latest News > All
Current | 2016 News | 2015 News | Prior to 2015

- - - - -
January 27, 2017
Safe Use of Acetaminophen – FDA Resources for Action
The FDA is providing educational messaging to extend the reach of its Safe Use of Acetaminophen 
campaign to educate the public on the proper use of over-the-counter (OTC) medicines and to warn that taking too 
much acetaminophen can be dangerous. The campaign website offers resources for consumers, health professionals, 
organizations, and campaign supporters on improving consumer safety.

Acetaminophen is an active ingredient found in hundreds of over-the-counter (OTC) and prescription medicines that 
are used to relieve pain and fever. It is also combined with other active ingredients in medicines that treat allergy, 
cough, colds, flu, and sleeplessness. In prescription medicines, acetaminophen is found with other active ingredients to 
treat moderate to severe pain. Using two or more medicines that contain acetaminophen or using more acetaminophen 
than directed can cause serious liver damage.

Related from NCPIE:   
Acetaminophen Safe Use Modules

January 23, 2017
FDA warns -- Pet Illness and Death from Human Cancer Medication
FDA is warning about the possibility of illness or death in pets exposed to the topical cancer drug fluorouracil cream 
USP 5% (5-FU). The agency cautioned pharmacists, health care providers, veterinarians, and pet owners that it has 
received reports of five dogs that became sick and died after accidentally ingesting the cream. People who use the 
drug should use care when storing and applying the drug if they are in a household with pets, FDA said, noting that 
even minute amounts can be dangerous for pets. FDA has not received any reports involving cats; however, they are 
also expected to be sensitive to the drug. The cream may also be marketed under the brand names Carac, Effudex, 
and Fluoroplex.

January 12, 2017
NEW CDC Tool – Antibiotic Resistance Investment Map
An interactive web app with state-by-state fact sheets describing CDC’s key investments to combat antibiotic 
resistance and protect patients across the nation.  Using fiscal year 2016 funding data, the AR Investment Map and 
fact sheets can be used to better understand how CDC supports AR activities locally. With these investments, the 
Centers for Disease Control & Prevention (CDC), in partnership with health departments, academia, and healthcare, is 
transforming how the nation combats and slows antibiotic resistance at all levels.

January 11, 2017
First NY Recovery High Schools Created to Help Young People in Recovery Finish School
New York’s Governor Cuomo announced in his 2017 State of the State report that he will propose legislation to create 
New York’s first recovery high schools in regions of the State hit especially by the disease of addiction --one upstate 
and one downstate, in partnership with local social service agencies.  Enrollment will be open to all high school 
students with a diagnosis of a substance abuse disorder and a commitment to recovery.  Recovery schools are “schools 
within school” where students in recovery can learn in a substance-free and supportive environment and have proven 
to be an effective model to help youth in recovery stay healthy and graduate.

January 5, 2017
FDA Podcast -- Agency’s Actions to Address the Opioid Epidemic
FDA’s Center for Drug Evaluation and Research (CDER) provides an audio podcast series, The Director’s Corner, 
featuring discussions by FDA’s CDER director, Janet Woodcock, MD. The latest podcast presents a discussion on 
various opioid safety labeling changes and opioid prescribing in the US.